Yashiro M, Carethers J M, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K, Boland C R
Department of Medicine, University of California, San Diego, La Jolla 92093-0688, USA.
Cancer Res. 2001 Mar 15;61(6):2676-83.
Colorectal adenomas can be morphologically classified as exophytic or flat. Polypoid cancers and cancers arising de novo (ie., without any adenomatous component) might be the results of genetic progression from exophytic and flat adenomas, respectively. In this study, we examined 94 morphologically distinct neoplastic specimens for mutations in K-RAS and analyzed 10 microsatellite loci tightly linked to the tumor suppressor genes APC, p53, DCC/SMAD4, hMSH2, and hMLH1. K-RAS mutations were significantly associated with exophytic adenomas [11 of 21 (52%)] compared to flat adenomas [2 of 13(15%), P < 0.03] and polypoid cancers [17 of 25 (68%)] compared to cancers arising de novo [7 of 25 (28%), P < 0.01]. Two polypoid cancer cases demonstrated three and four different K-RAS mutations, respectively, suggesting multiple areas of clonal expansion. Cancers arising de novo were significantly associated with loss of heterozygosity (LOH) at chromosome 3p compared to pol ypoid cancers [6 of 18(33%) versus 1 of 20(5%), P < 0.03], whereas the prevalence of LOH at chromosomes 2p, 5q, 17p, and 18q and microsatellite instability were not different between the groups. For all cancers, LOH at chromosomes 17p and 18q occurred in 47 and 51%, respectively. However, LOH at 17p and 18q occurred in 0 and 16% of benign lesions, respectively, suggesting their role in malignant transformation. There was no difference in LOH at chromosomes 17p and 18q between exophytic and flat lesions. These findings suggest that (a) mutant K-RAS is associated with the exophytic growth of colonic neoplasms, and that (b) some colorectal cancers arising de novo lose chromosome 3p during their evolution, which is not seen in polypoid cancers. Half of all cancers lose chromosomes 17p and 18q at or near the malignant transition of benign lesions as reported previously, irrespective of morphology. There may be more than one genetic avenue for colorectal cancer formation, and this correlates with the morphological characteristics.
结直肠腺瘤在形态学上可分为外生性或扁平性。息肉状癌和原发性癌(即无任何腺瘤成分)可能分别是外生性和扁平性腺瘤基因进展的结果。在本研究中,我们检测了94个形态学上不同的肿瘤标本中的K-RAS突变,并分析了与肿瘤抑制基因APC、p53、DCC/SMAD4、hMSH2和hMLH1紧密连锁的10个微卫星位点。与扁平腺瘤[13例中的2例(15%),P<0.03]相比,K-RAS突变与外生性腺瘤显著相关[21例中的11例(52%)];与原发性癌[25例中的7例(28%),P<0.01]相比,与息肉状癌[25例中的17例(68%)]显著相关。2例息肉状癌病例分别显示出3种和4种不同的K-RAS突变,提示存在多个克隆扩增区域。与息肉状癌相比,原发性癌与3号染色体短臂杂合性缺失(LOH)显著相关[18例中的6例(33%)对20例中的1例(5%),P<0.03],而2号染色体短臂、5号染色体长臂、17号染色体短臂和18号染色体长臂的LOH发生率以及微卫星不稳定性在两组之间无差异。对于所有癌症,17号染色体短臂和18号染色体长臂的LOH发生率分别为47%和51%。然而,17号染色体短臂和18号染色体长臂的LOH分别发生在0%和16%的良性病变中,提示它们在恶性转化中的作用。外生性病变和扁平性病变在17号染色体短臂和18号染色体长臂的LOH方面无差异。这些发现表明:(a)突变的K-RAS与结肠肿瘤的外生性生长相关;(b)一些原发性结直肠癌在其发展过程中丢失3号染色体短臂,而息肉状癌未见此现象。如先前报道,所有癌症中有一半在良性病变的恶性转化时或接近恶性转化时丢失17号染色体短臂和18号染色体长臂,与形态无关。结直肠癌的形成可能有不止一条遗传途径,且这与形态学特征相关。